These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2834296)

  • 1. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with LY146032.
    Norden CW; Niederriter K
    Infection; 1988; 16(1):27. PubMed ID: 2834296
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Adams K
    Antimicrob Agents Chemother; 1989 May; 33(5):689-92. PubMed ID: 2546488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic experimental Staphylococcus aureus osteomyelitis with LY146032 and vancomycin.
    Luu QN; Buxton TB; Nelson DR; Rissing JP
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):562-3. PubMed ID: 2548867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of daptomycin combined with rifampicin for the treatment of experimental meticillin-resistant Staphylococcus aureus (MRSA) acute osteomyelitis.
    Lefebvre M; Jacqueline C; Amador G; Le Mabecque V; Miegeville A; Potel G; Caillon J; Asseray N
    Int J Antimicrob Agents; 2010 Dec; 36(6):542-4. PubMed ID: 20851576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Marty FM; Yeh WW; Wennersten CB; Venkataraman L; Albano E; Alyea EP; Gold HS; Baden LR; Pillai SK
    J Clin Microbiol; 2006 Feb; 44(2):595-7. PubMed ID: 16455920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with teicoplanin.
    Norden CW; Niederreiter K; Shinners EM
    Infection; 1986; 14(3):136-8. PubMed ID: 2942488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clindamycin treatment of experimental chronic osteomyelitis due to Staphylococcus aureus.
    Norden CW; Shinners E; Niederriter K
    J Infect Dis; 1986 May; 153(5):956-9. PubMed ID: 3701108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of daptomycin for MRSA osteomyelitis and joint infection.
    Burns CA
    Scand J Infect Dis; 2008; 40(2):183-6. PubMed ID: 17852899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro biofilm model of Staphylococcus aureus infection of bone.
    Sweeney E; Lovering AM; Bowker KE; MacGowan AP; Nelson SM
    Lett Appl Microbiol; 2019 Apr; 68(4):294-302. PubMed ID: 30770577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin treatment of Staphylococcus aureus experimental chronic osteomyelitis.
    Rouse MS; Piper KE; Jacobson M; Jacofsky DJ; Steckelberg JM; Patel R
    J Antimicrob Chemother; 2006 Feb; 57(2):301-5. PubMed ID: 16361330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in experimental models of osteomyelitis.
    Cassat JE; Skaar EP
    Expert Rev Anti Infect Ther; 2013 Dec; 11(12):1263-5. PubMed ID: 24215241
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis associated with reduced susceptibility to daptomycin.
    Vikram HR; Havill NL; Koeth LM; Boyce JM
    J Clin Microbiol; 2005 Oct; 43(10):5384-7. PubMed ID: 16208025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
    Twilla JD; Gelfand MS; Cleveland KO; Usery JB
    J Antimicrob Chemother; 2011 Nov; 66(11):2675-7. PubMed ID: 21831987
    [No Abstract]   [Full Text] [Related]  

  • 14. Cefepime for treatment of experimental chronic osteomyelitis due to Staphylococcus aureus.
    Norden CW; Gill EA
    J Infect Dis; 1990 Nov; 162(5):1218-9. PubMed ID: 2230253
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of experimental chronic osteomyelitis due to Staphylococcus aureus with ampicillin/sulbactam.
    Norden CW; Budinsky A
    J Infect Dis; 1990 Jan; 161(1):52-3. PubMed ID: 2295859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Osteomyelitis associated with Staphylococcus aureus infection and reduced susceptibility to vancomycin treated with daptomycin].
    Araujo F; Conde Estevez D; Encinas Barrios C
    Farm Hosp; 2012; 36(5):449-51. PubMed ID: 22484104
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative evaluation of cefamandole and cephalothin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Wilson KJ
    J Bone Joint Surg Am; 1983 Apr; 65(4):507-13. PubMed ID: 6833327
    [No Abstract]   [Full Text] [Related]  

  • 18. Ceftaroline in the treatment of concomitant methicillin-resistant and daptomycin-non-susceptible Staphylococcus aureus infective endocarditis and osteomyelitis: case report.
    Jongsma K; Joson J; Heidari A
    J Antimicrob Chemother; 2013 Jun; 68(6):1444-5. PubMed ID: 23341127
    [No Abstract]   [Full Text] [Related]  

  • 19. MRSA and osteomyelitis of the foot in diabetes.
    Game F; Jeffcoate W
    Diabet Med; 2004 Sep; 21 Suppl 4():16-9. PubMed ID: 15315521
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Staphylococcus aureus-induced chronic osteomyelitis with bone-like hydroxyapatite/poly amino acid loaded with rifapentine microspheres.
    Yan L; Jiang DM; Cao ZD; Wu J; Wang X; Wang ZL; Li YJ; Yi YF
    Drug Des Devel Ther; 2015; 9():3665-76. PubMed ID: 26213463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.